Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Turning Point Therapeutics, Inc.
Eastern Cooperative Oncology Group
Washington University School of Medicine
Arvinas Inc.
ALX Oncology Inc.
University of Colorado, Denver
University of Nebraska
Var2 Pharmaceuticals
University Health Network, Toronto
Massive Bio, Inc.
Washington University School of Medicine
A2 Biotherapeutics Inc.
Centre for Research and Technology Hellas
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Vyriad, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Second Affiliated Hospital of Guangzhou Medical University
University of Calgary